Combination of serum lipids and cancer antigens as a novel marker for colon cancer diagnosis

T Li, Y Qian, H Li, J Deng - Lipids in Health and Disease, 2018 - Springer
Background Colon cancer is a malignancy of the large intestine with high mortality and
economic burden. Recent studies reveal a new relationship between blood lipids and the …

Altered serum annexin A2 might Be a new potential diagnostic biomarker in human colorectal cancer

D Hu, B Shen, M Yu, X Zha, Y Zhou… - Annals of Clinical & …, 2020 - Assoc Clin Scientists
Objective. Annexin A2 is a calcium dependent phospholipid binding protein that is a
biomarker in cancers. However, the value of serum Annexin A2 in the diagnosis of colorectal …

Potential Association of Poly (ADP-ribose) Polymerase-1 (PARP-1) with CD133 and G2/M as Independent Predictors in Colorectal Cancer Development.

HM El-Emshaty, AA Abdelfatah, H Ismail… - Biochemistry …, 2019 - journals.ekb.eg
Objective: PARP inhibitor therapy was intensively investigated in colorectal cancer (CRC).
Therefore, our aim was to investigate the potential association of DNA repair protein PARP-1 …

CK20 mRNA expression in serum as a biomarker for colorectal cancer diagnosis: A meta-analysis

B Ji, X Cheng, X Cai, C Kong, Q Yang, T Fu, Y Wang… - Open …, 2017 - degruyter.com
The aim of this study was to evaluate the diagnostic value of serumCK20 mRNA as a
biomarker for colorectal cancer diagnosis by meta-analysis. Clinical studies related to serum …

[PDF][PDF] Study of Glutathione-S-Transferase, Cancer Embryonic Antigen and Carbohydrate Antigen 19-9 in Ulcerative Colitis and Colorectal Cancer

FS Mohamed, MM Elkady, EF Mohamed… - Basic Science of …, 2015 - researchgate.net
Background: Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) with a
high risk of colorectal cancer (CRC), which is a major cause of cancer morbidity and …

[引用][C] 血常规, 生化以及肿瘤标志物联合检测在结直肠癌患者筛查中的应用价值

刘静 - 中国卫生检验杂志, 2016

[引用][C] 血清肿瘤标志物在胰腺癌早期诊断中的研究进展

方恒忠, 陈炯 - 国际外科学杂志, 2015